Member for: 6 days
Type: Registered user
Full name:
Location:
Website: https://www.selleckchem.com/products/go-203.html
About: Population-adjusted indirect therapy comparability of the SOLO1 and PAOLA-1/ENGOT-ov25 tests analyzing routine maintenance olaparib or bevacizumab or the mix of both in recently clinically determined, advanced BRCA-mutated ovarian cancers.

Activity by fangchive5

Score: 100 points (ranked #3,103)
Media: 0
Comments: 0
Replies: 0
Voted on: 0 Media, 0 Comments
Gave out: 0 up votes, 0 down votes
Received: 0 up votes, 0 down votes